Clinical Trials
4 trialsNCT05218603 2022-09-16
Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT
PETHEMA Foundation
Unknown
NCT04678089 2022-04-28
Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics
Beijing Chao Yang Hospital
Unknown
NCT02976272 2019-07-01
SENSIB
University Hospital, Clermont-Ferrand
Unknown
NCT02797041 2016-06-14
REBOUND
IRCCS Centro di Riferimento Oncologico della Basilicata
Unknown